Dr. Roberta Lotti honoured for a pioneering work on PC111, reinforcing Scinai's strategic option agreement to acquire the Italian biotech company Pincell srl. PC111 is targeting the soluble form of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback